One of the world’s largest flavors and fragrances companies is paying $7.1 billion for Haifa based Frutarom.

Israel’s Teva is partnering with Japan’s Heptares to develop a treatment for migraines, and researchers at Ben Gurion University have discovered that sufferers of diabetic foot ulcers frequently also have substantially impaired cognitive function.